5,305
Views
9
CrossRef citations to date
0
Altmetric
Original Research

An evaluation of the use and handling errors of currently available recombinant human follicle-stimulating hormone pen injectors by women with infertility and fertility nurses

, , , , & ORCID Icon
Pages 1003-1014 | Received 28 Jun 2019, Accepted 30 Jul 2019, Published online: 14 Aug 2019

References

  • Huisman D, Raymakers X, Hoomans EH. Understanding the burden of ovarian stimulation: fertility expert and patient perceptions. Reprod Biomed Online. 2009;19(Suppl 2):5–10. PubMed PMID: 19891842; eng.
  • Brandes M, van der Steen JO, Bokdam SB, et al. When and why do subfertile couples discontinue their fertility care? A longitudinal cohort study in a secondary care subfertility population. Hum Reprod. 2009 Dec;24(12):3127–3135. PubMed PMID: 19783833; eng.
  • Jeannerot F, Studeli T, Gunther-LaVergne L, et al. Usability engineering study in the European union of a redesigned follitropin alfa pen injector for infertility treatment. Expert Opin Drug Deliv. 2016 Sep;13(9):1221–1229. PubMed PMID: 27329677.
  • Schertz J, Worton H. Nurse evaluation of the redesigned fertility pen injector: a questionnaire-based observational survey. Expert Opin Drug Deliv. 2018 May;15(5):435–442. PubMed PMID: 29521156; eng.
  • Schertz J, Worton H. Patient evaluation of the redesigned follitropin alfa pen injector. Expert Opin Drug Deliv. 2017 Apr;14(4):473–481. PubMed PMID: 28140682; eng.
  • Abbotts C, Salgado-Braga C, Audibert-Gros C. A redesigned follitropin alfa pen injector for infertility: results of a market research study. Patient Prefer Adherence. 2011;5:315–331. PubMed PMID: 21792303; PubMed Central PMCID: PMC3140313. eng.
  • Gibreel A, Bhattacharya S. Recombinant follitropin alfa/lutropin alfa in fertility treatment. Biologics. 2010 Feb 4;4:5–17. PubMed PMID: 20161981; PubMed Central PMCID: PMC2819896. eng.
  • Quintero LAM, Verdú V, de la Fuente Bitaine L, et al. An evaluation by potential IVF/Donor Oocyte patients of the use and handling of the Bemfola® Pen compared with the Gonal-f® Pen and Puregon Pen®. Revista Iberoamericana De Fertilidad. 2017;34:64–73.
  • Imthurn B, McVeigh E, Stiller R, et al. Evaluation of the use and handling of three different pen systems considered for in vitro fertilization treatment. Expert Opin Drug Deliv. 2014 Dec;11(12):1859–1864. . PubMed PMID: 25325925; eng.
  • van Overbeeke E, Whichello C, Janssens R, et al. Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discov Today. 2019 Jan;24(1):57–68. PubMed PMID: 30266656; eng.
  • Lankreijer K, D’Hooghe TM, Apers S, et al. Hormonal medication in medically assisted reproduction: a systematic review of assessments from patients. Reprod Biomed Online. 2019 Mar;38(3):341–363. PubMed PMID: 30770286; eng.
  • Lankreijer K, D’Hooghe T, Sermeus W, et al. Development and validation of the FertiMed questionnaire assessing patients’ experiences with hormonal fertility medication. Hum Reprod. 2016 Aug;31(8):1799–1808. PubMed PMID: 27220980; eng.
  • Dancet EA, Nelen WL, Sermeus W, et al. The patients’ perspective on fertility care: a systematic review. Hum Reprod Update. 2010 ( Sep-Oct);16(5):467–487. doi: 10.1093/humupd/dmq004. PubMed PMID: 20223789; eng.
  • Dancet EA, D’Hooghe TM, van der Veen F, et al. “Patient-centered fertility treatment”: what is required? Fertil Steril. 2014;101(4):924–926.
  • Dancet EA, D’Hooghe TM, Sermeus W, et al. Patients from across Europe have similar views on patient-centred care: an international multilingual qualitative study in infertility care. Hum Reprod. 2012 Jun;27(6):1702–1711. PubMed PMID: 22427309; eng.
  • Dancet EA, D’Hooghe TM, Spiessens C, et al. Quality indicators for all dimensions of infertility care quality: consensus between professionals and patients. Hum Reprod. 2013 Jun;28(6):1584–1597. PubMed PMID: 23508250; eng.
  • Mahony MC, Patterson P, Hayward B, et al. Human factors engineering and design validation for the redesigned follitropin alfa pen injection device. Expert Opin Drug Deliv. 2015 May;12(5):715–725. PubMed PMID: 25895897; PubMed Central PMCID: PMC4496816. eng.
  • Zitoun P, Parikh J, Nijs M, et al. Analysis of patient and nurse preferences for self-administered FSH injection devices in select European markets. Int J Womens Health. 2019;11:11–21. PubMed PMID: 30662286; PubMed Central PMCID: PMC6327888. eng.
  • Jeannerot F, Cusin A, Schertz J. Dose accuracy of the redesigned follitropin alfa pen injector for infertility treatment. Expert Opin Drug Deliv. 2016 Dec;13(12):1661–1669. PubMed PMID: 27636195.
  • Saunders H, de la Fuente Bitaine L, Eftekhar C, et al. Functionality of a novel follitropin alfa pen injector: results from human factor interactions by patients and nurses. Expert Opin Drug Deliv. 2018 Jun;15(6):549–558. PubMed PMID: 29595399; eng.